News

Filter

Current filters:

CiplaMarkets & Marketing

1 to 9 of 12 results

Cipla links with SII for affordable pediatric vaccines in Europe

20-11-2014

The European subsidiary of Indian drugmaker Cipla has entered a distribution agreement with Serum Institute…

CiplaEuropeGenericsMarkets & MarketingSerum Institute of IndiaVaccines

India’s Cipla calls for revocation of Novartis’ Onbrez patents

01-11-2014

Indian drugmaker Cipla has asked the government to revoke five patents that Swiss pharma major Novartis…

CiplaIndiaMarkets & MarketingNovartisOnbrezPatentsPharmaceuticalRespiratory and PulmonaryUnibrez

Cipla in deal with Teva for South African marketing

Cipla in deal with Teva for South African marketing

09-10-2014

Indian drugmaker Cipla has entered into a collaboration with Israel's Teva Pharmaceuticals Industries,…

CiplaGenericsMarkets & MarketingSouth AfricaTeva Pharmaceuticals Industries

Cipla in deal with S&D Pharma to enter Czech Republic and Slovakia generics market

Cipla in deal with S&D Pharma to enter Czech Republic and Slovakia generics market

11-09-2014

Indian drugmaker Cipla has entered a commercial collaboration with the UK’s S&D Pharma in the Czech…

CiplaCzech RepublicEastern EuropeFluticasone Propionate and SalmeterolFullhaleGenericsMarkets & MarketingRespiratory and PulmonaryS&D Pharma

Cipla's generic of GSK's Advair for asthma marks expansion into Europe

Cipla's generic of GSK's Advair for asthma marks expansion into Europe

01-09-2014

Indian generic drugmaker Cipla has entered the respiratory market in Germany and Sweden with its Serroflo…

AdvairCiplaGenericsIndiaMarkets & MarketingRespiratory and Pulmonary

Cipla to invest £100 million in its UK subsidiary

Cipla to invest £100 million in its UK subsidiary

07-07-2014

Indian drugmaker Cipla has decided to make a significant investment in its UK subsidiary over the next…

CiplaFinancialGenericsMarkets & MarketingResearchUK

Cipla links with Hetero for biosimilar Aranesp; M&A in Yemen

30-06-2014

Cipla has collaborated with fellow Indian drugmaker Hetero to launch a biosimilar of the drug darbepoetin…

ActoriseAmgenAranespBiosimilarsCiplaGenericsHeteroIndiaMarkets & MarketingMergers & AcquisitionsOncologyRest of the World

Merck & Co partners with Cipla for Indian marketing of raltegravir

Merck & Co partners with Cipla for Indian marketing of raltegravir

21-02-2014

US pharma giant Merck & Co, known as MSD outside North America, has announced the formation of an India-specific…

Anti-viralsAsia-PacificCiplaIndiaIsentressMarkets & MarketingMerck & CoPharmaceuticalRaltegravir Tablets

1 to 9 of 12 results

COMPANY SPOTLIGHT

Menarini

Back to top